Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Bile Duct Neoplasms 3Stomach Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Esophageal Neoplasms 2Colorectal Neoplasms 2Venous Thromboembolism 1Supratentorial Neoplasms 1Sigmoid Neoplasms 1Recurrence 1Rectal Neoplasms 1Ovarian Neoplasms 1Neoplasm Metastasis 1Glioma 1Gallbladder Neoplasms 1Erectile Dysfunction 1Endometrial Neoplasms 1Dyskinesias 1Diarrhea 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Loperamide 4Irinotecan 4Probiotics 3Fecal Microbiota Transplantation 3Octreotide 2Leucovorin 2Fluorouracil 2Calcium Aluminosilicate 2telotristat ethyl 1shosaiko-to 1maltodextrin 1ceterizine hydrochloride 1capivasertib 1cabazitaxel 1bile acid binding proteins 1XRP6258 1Theophylline 1Temozolomide 1Surveys and Questionnaires 1Sulfasalazine 1Sugars 1Standard of Care 1Raloxifene Hydrochloride 1Radiation 1Prednisone 1Oxaliplatin 1Long-Term Synaptic Depression 1Injections 1Granulocyte Colony-Stimulating Factor 1Fulvestrant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diarrhea × Long-Term Synaptic Depression × Clear all
NCT04926545 2024-07-30

XCHT for Irinotecan-Induced Gut Toxicities (Run-in Study)

Guangzhou University of Traditional Chinese Medicine

Phase NA Completed
24 enrolled

Diarrhea, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡